Treating Hodgkin lymphoma in the new millennium: Relapsed and refractory disease
Sign Up to like & getrecommendations! Published in 2019 at "Hematological Oncology"
DOI: 10.1002/hon.2589
Abstract: Although the majority of patients with Hodgkin lymphoma are cured with initial therapy, 10% to 15% of patients with early stage disease and 15% to 30% of patients with advanced disease have primary refractory or… read more here.
Keywords: lymphoma; hodgkin lymphoma; disease; lymphoma new ... See more keywords